
|Videos|November 30, 2020
Conference Preview: SABCS 2020
Author(s)Targeted Oncology
The most interesting developments and approvals in breast cancer treatment in the last year and expectations regarding data that will be presented on at the upcoming 2020 San Antonio Breast Cancer Symposium.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
3
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
4
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
5


































